Orbimed Advisors LLC reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 20.8% during the 1st quarter, Holdings Channel.com reports. The firm owned 208,700 shares of the medical equipment provider’s stock after selling 54,700 shares during the quarter. Intuitive Surgical comprises about 1.8% of Orbimed Advisors LLC’s holdings, making the stock its 14th largest position. Orbimed Advisors LLC’s holdings in Intuitive Surgical were worth $96,209,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. Norges Bank bought a new position in Intuitive Surgical in the 4th quarter worth approximately $2,856,987,000. J. Stern & Co. LLP boosted its position in Intuitive Surgical by 18,504.6% in the 4th quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock valued at $1,204,788,000 after buying an additional 2,115,814 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in Intuitive Surgical by 1,043.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock valued at $760,124,000 after buying an additional 1,224,734 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its stake in shares of Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after buying an additional 1,027,475 shares during the period. Finally, Polen Capital Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $477,225,000. Institutional investors and hedge funds own 83.64% of the company’s stock.
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total value of $169,656.00. Following the transaction, the executive vice president owned 5,720 shares of the company’s stock, valued at $2,426,080.80. The trade was a 6.54% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 7,169 shares of company stock valued at $3,059,135. 0.60% of the stock is currently owned by company insiders.
Intuitive Surgical Price Performance
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same period last year, the company earned $1.81 EPS. The firm’s revenue was up 18.4% on a year-over-year basis. Research analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several equities analysts have recently issued reports on ISRG shares. The Goldman Sachs Group set a $558.00 price target on Intuitive Surgical in a research note on Wednesday, May 27th. Raymond James Financial reiterated an “outperform” rating and issued a $483.00 price objective (down from $577.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. Mizuho set a $500.00 price objective on Intuitive Surgical and gave the stock a “neutral” rating in a report on Wednesday, July 15th. JPMorgan Chase & Co. cut their target price on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating on the stock in a research report on Friday, July 17th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. Twenty-one analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $523.46.
Get Our Latest Analysis on ISRG
Trending Headlines about Intuitive Surgical
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: Intuitive Surgical unveiled a five-layer AI framework for its surgical platforms and demonstrated live telesurgical collaboration, signaling that it is embedding AI into clinical workflows and expanding the capabilities of its robotic surgery ecosystem. Intuitive Surgical (ISRG) Unveils Five Layer AI Plan And Live Telesurgery Demo
- Positive Sentiment: Several analyst-focused pieces framed ISRG as a strong long-term MedTech growth name, highlighting its innovation pipeline, recurring revenue, and high switching costs for surgeons. Why Intuitive Surgical, Inc. (ISRG) is a Top Growth Stock for the Long-Term
- Positive Sentiment: Coverage around Wall Street recommendations continued to describe Intuitive Surgical as a favored investment idea, supporting sentiment around the company’s durable business model. Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?
- Positive Sentiment: CONMED’s expanded AirSeal indication for da Vinci 5 compatibility may help broaden use across Intuitive Surgical’s platform, reinforcing the ecosystem around its robotic systems. CONMED Expands AirSeal Robotic Solution for da Vinci 5 Hex Cannula
- Neutral Sentiment: Intuitive Surgical remains a frequent subject of analyst and stock-report coverage, but these pieces are mostly commentary rather than new fundamentals, so they are unlikely to move the stock on their own. Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors
- Neutral Sentiment: Short-interest data showed no meaningful change in reported shares, offering little direct signal for investors.
- Negative Sentiment: Some articles emphasized that ISRG’s shares have pulled back sharply and questioned whether growth expectations in its biggest market are changing, which can weigh on sentiment. Intuitive Surgical Stock Is On Sale, But Is the Growth Story Changing?
- Negative Sentiment: J&J’s progress on Ottava was viewed as a reminder that competition in robotic surgery is intensifying, adding pressure to Intuitive Surgical’s market leadership narrative. J&J Finally Has a Rival to da Vinci. 1 Number in Intuitive Surgical’s Last Quarter Says It Won’t Be Enough to Move the Needle for JNJ Stock.
Intuitive Surgical Company Profile
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
